Lipid trafficking score

1. Lipid trafficking score is associated with low-density lipoprotein cholesterol in humans.

   “Most subjects with a poor lipid trafficking score did not reach low-density lipoprotein cholesterol (LDL-C) target levels on statin monotherapy.”

   Humanson statin monotherapy

   Linking variability of leukocyte lipid metabolism to circulating lipids, lipoprotein composition and cardiovascular risk in the Finnish adult population

   AHA Scientific Sessions 2025 abstract·3 Nov 2025

More on Low-density lipoprotein cholesterol

1. Lipid trafficking score is associated with stroke in humans.

   “had higher odds for myocardial infarction and stroke when compared to the rest of the subjects with equivalent treatment”

   Humansin individuals receiving high-intensity statin therapy

   Linking variability of leukocyte lipid metabolism to circulating lipids, lipoprotein composition and cardiovascular risk in the Finnish adult population

   AHA Scientific Sessions 2025 abstract·3 Nov 2025

More on Stroke

1. Lipid trafficking score is associated with myocardial infarction in humans.

   “had higher odds for myocardial infarction and stroke when compared to the rest of the subjects with equivalent treatment”

   Humansin individuals receiving high-intensity statin therapy

   Linking variability of leukocyte lipid metabolism to circulating lipids, lipoprotein composition and cardiovascular risk in the Finnish adult population

   AHA Scientific Sessions 2025 abstract·3 Nov 2025

More on Myocardial infarction

1. Lipid trafficking score is associated with pro-atherogenic lipoproteins in humans.

   “Of individuals receiving high-intensity statin therapy those with lower lipid trafficking scores displayed higher circulating concentrations of several pro-atherogenic lipoproteins”

   Humansin individuals receiving high-intensity statin therapy

   Linking variability of leukocyte lipid metabolism to circulating lipids, lipoprotein composition and cardiovascular risk in the Finnish adult population

   AHA Scientific Sessions 2025 abstract·3 Nov 2025

More on Pro-atherogenic lipoproteins